Global Cancer Targeted Therapy Market Data Survey Report 2013-2025
Table of Contents
1 Global Market Overview
- 1.1 Scope of Statistics
- 1.1.1 Scope of Products
- 1.1.2 Scope of Manufacturers
- 1.1.3 Scope of Application
- 1.1.4 Scope of Type
- 1.1.5 Scope of Regions/Countries
- 1.2 Global Market Size
2 Regional Market
- 2.1 Regional Production
- 2.2 Regional Demand
- 2.3 Regional Trade
3 Key Manufacturers
- 3.1 Advaxis
- 3.1.1 Company Information
- 3.1.2 Product & Services
- 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.1.4 Recent Development
- 3.2 Bind Therapeutics
- 3.2.1 Company Information
- 3.2.2 Product & Services
- 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.2.4 Recent Development
- 3.3 Boehringer Ingelheim
- 3.3.1 Company Information
- 3.3.2 Product & Services
- 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.3.4 Recent Development
- 3.4 Bristol Mayer Squibb
- 3.4.1 Company Information
- 3.4.2 Product & Services
- 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.4.4 Recent Development
- 3.5 Celldex Therapeutics
- 3.5.1 Company Information
- 3.5.2 Product & Services
- 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.5.4 Recent Development
- 3.6 Dendreon Corporation
- 3.6.1 Company Information
- 3.6.2 Product & Services
- 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.6.4 Recent Development
- 3.7 Eli Lily
- 3.7.1 Company Information
- 3.7.2 Product & Services
- 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.7.4 Recent Development
- 3.8 GalaxoSmithKline
- 3.8.1 Company Information
- 3.8.2 Product & Services
- 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.8.4 Recent Development
- 3.9 Galena Biopharma
- 3.9.1 Company Information
- 3.9.2 Product & Services
- 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.9.4 Recent Development
- 3.10 Genetech
- 3.10.1 Company Information
- 3.10.2 Product & Services
- 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.10.4 Recent Development
- 3.11 ImmunoCellular Therapeutics
- 3.11.1 Company Information
- 3.11.2 Product & Services
- 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.11.4 Recent Development
- 3.12 ImmunoGen
- 3.12.1 Company Information
- 3.12.2 Product & Services
- 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.12.4 Recent Development
- 3.13 Inovio Pharmaceuticals
- 3.13.1 Company Information
- 3.13.2 Product & Services
- 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.13.4 Recent Development
- 3.14 Johnson & Johnson
- 3.14.1 Company Information
- 3.14.2 Product & Services
- 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.14.4 Recent Development
- 3.15 NeoStem Oncology
- 3.15.1 Company Information
- 3.15.2 Product & Services
- 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.15.4 Recent Development
- 3.16 NewLink Genetics
- 3.16.1 Company Information
- 3.16.2 Product & Services
- 3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.16.4 Recent Development
- 3.17 Northwest Biotherapeutics
- 3.17.1 Company Information
- 3.17.2 Product & Services
- 3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.17.4 Recent Development
- 3.18 Merck
- 3.18.1 Company Information
- 3.18.2 Product & Services
- 3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.18.4 Recent Development
- 3.19 Novartis
- 3.19.1 Company Information
- 3.19.2 Product & Services
- 3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.19.4 Recent Development
- 3.20 Peregrine Pharmaceuticals
- 3.20.1 Company Information
- 3.20.2 Product & Services
- 3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.20.4 Recent Development
- 3.21 Pfizer
- 3.21.1 Company Information
- 3.21.2 Product & Services
- 3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.21.4 Recent Development
- 3.22 Roche
- 3.22.1 Company Information
- 3.22.2 Product & Services
- 3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.22.4 Recent Development
- 3.23 Sanofi
- 3.23.1 Company Information
- 3.23.2 Product & Services
- 3.23.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.23.4 Recent Development
- 3.24 Seattle Genetics
- 3.24.1 Company Information
- 3.24.2 Product & Services
- 3.24.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.25 Teva
- 3.25.1 Company Information
- 3.25.2 Product & Services
- 3.25.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
- 4.1 Hospital
- 4.1.1 Overview
- 4.1.2 Hospital Market Size and Forecast
- 4.2 Clinic
- 4.2.1 Overview
- 4.2.2 Clinic Market Size and Forecast
- 4.3 Others
- 4.3.1 Overview
- 4.3.2 Others Market Size and Forecast
5 Market by Type
5.By Tumor Antigens As Targets of Antibodies
- 5.1 Tumor Antigens As Targets of Antibodies
- 5.1.1 Overview
- 5.1.2 Tumor Antigens As Targets of Antibodies Market Size and Forecast
- 5.2 Development of Antibodies for Clinical Purposes
- 5.2.1 Overview
- 5.2.2 Development of Antibodies for Clinical Purposes Market Size and Forecast
- 5.3 Complement Dependent Cytotoxicity (CDC)
- 5.3.1 Overview
- 5.3.2 Complement Dependent Cytotoxicity (CDC) Market Size and Forecast
- 5.4 Signal Transduction Changes
- 5.4.1 Overview
- 5.4.2 Signal Transduction Changes Market Size and Forecast
6 Price Overview
- 6.1 Price by Manufacturers
- 6.2 Price by Application
- 6.3 Price by Type
7 Conclusion
Summary
The global Cancer Targeted Therapy market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Advaxis
Bind Therapeutics
Boehringer Ingelheim
Bristol Mayer Squibb
Celldex Therapeutics
Dendreon Corporation
Eli Lily
GalaxoSmithKline
Galena Biopharma
Genetech
ImmunoCellular Therapeutics
ImmunoGen
Inovio Pharmaceuticals
Johnson & Johnson
NeoStem Oncology
NewLink Genetics
Northwest Biotherapeutics
Merck
Novartis
Peregrine Pharmaceuticals
Pfizer
Roche
Sanofi
Seattle Genetics
Teva
Major applications as follows:
Hospital
Clinic
Others
Major Type as follows:
Tumor Antigens As Targets of Antibodies
Development of Antibodies for Clinical Purposes
Complement Dependent Cytotoxicity (CDC)
Signal Transduction Changes
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa